Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Simian Virus 40 Dna in Immunocompetent Children With Respiratory Disease Publisher Pubmed



Kiasari BA1 ; Fallah FH2 ; Koohi MK3 ; Duarte PM4 ; Tazerji SS5, 6 ; Fawzy M7
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Virology, Faculty of Veterinary Medicine, University of Tehran, Tehran, Iran
  2. 2. Department of Allergy and Clinical Immunology, Children's Medical Centre, Tehran University of Medical Sciences (TUMS), Tehran, Iran
  3. 3. Department of Comparative Biosciences, Faculty of Veterinary Medicine, University of Tehran, Tehran, Iran
  4. 4. University of Cuiaba Primavera do Leste – Mato Grosso – Brazil Programa de Pos-Graduacao em Biociencia Animal (PPGBA) - UFRPE Federal Rural University of Pernambuco, Pernambuco, Recife, Brazil
  5. 5. Department of Clinical Science, Faculty of Specialized Veterinary Sciences, Science and Research Branch, Islamic Azad University, Tehran, Iran
  6. 6. Department of Clinical Science, Young Researchers and Elites Club, Science and Research Branch, Islamic Azad University, Tehran, Iran
  7. 7. Department of Virology, Faculty of Veterinary Medicine, Suez Canal University, Ismailia, Egypt

Source: Journal of Medical Virology Published:2022


Abstract

Evidence of Simian virus 40 (SV40) DNA sequences or gene products has been reported in a variety of organ systems in humans. However, the route of transmission and the significance of SV40 polyomavirus infection in human are unknown. The aim of study was to characterize the frequency of SV40 infection in immunocompetent and immunocompromised patients with respiratory diseases. Respiratory specimens from patients with respiratory tract illness obtained from nasopharyngeal aspirates (n = 280) were screened for SV40 polyomavirus using real-time PCR; coinfection with other viruses was examined. Positive results were confirmed with sequencing. Of the 280 samples analysed, 2 (0.71%) were positive for SV40. SV40 was identified in nasopharyngeal aspirate samples from children aged 8 and 14 months who were immunocompetent. Both patients had upper or lower respiratory tract infection. Coinfections with other viruses were found in 50% of the SV40 positive samples. The data suggest that SV40 can infect respiratory tract, that respiratory tract may represent a route of transmission or a site for virus persistence, and that with the high rate of co-infection, SV40 may not involved in respiratory diseases. © 2022 Wiley Periodicals LLC.